To test the senolytic potency of CypD inhibition, we used the previously mentioned irradiated-IMR90 and bleomycin-A549 cells, as well as human melanoma SK-MEL-103 cells (abbreviated as SK-MEL) treated with palbociclib. This evidence concerns the gene PPIF and melanoma.